Disease on EC 1.11.2.2 - myeloperoxidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Septic
Umbilical cord 'pseudo-vasculitis' following second trimester fetal death: a clinicopathological and immunohistochemical study of 13 cases.
Abortion, Spontaneous
[Human placental myeloperoxidase in miscarriage]
Abscess
Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
Partial characterization of a bactericidal system in staphylococcal abscesses.
Acatalasia
Catalase deficiency in myeloperoxidase deficient polymorphonuclear leucocytes from chicken.
Acidosis
Acidosis stimulates nitric oxide production and lung damage in rats.
Extracellular acidification induces human neutrophil activation.
The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats.
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition.
Urethan anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release.
Acidosis, Lactic
Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on haemodynamics or regional microvascular flow.
Acne Vulgaris
Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris.
Acquired Immunodeficiency Syndrome
Disseminated tubuloreticular inclusions in acquired immunodeficiency syndrome (AIDS).
Acute Coronary Syndrome
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome.
A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome.
Amperometric myeloperoxidase immunoassay based on the use of CuPdPt nanowire networks.
Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.
C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction.
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
Identifying patients for early discharge: Performance of decision rules among patients with acute chest pain.
Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
Letter by schindhelm regarding article, "high levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".
Long-term Prognostic Value of Myeloperoxidase on Acute Coronary Syndrome-A Meta-analysis.
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.
Multimarker panel to rule out acute coronary syndromes in low-risk patients.
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
Myeloperoxidase in the acute coronary syndrome: Equal concentrations at any time of day?
Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes.
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
Novel biomarkers for cardiovascular risk prediction.
Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome.
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels.
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.
Response: myeloperoxidase as a biomarker in acute coronary syndrome: a trap or a treasure.
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain.
Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia.
Serial Analyses of C-Reactive Protein and Myeloperoxidase in Acute Coronary Syndrome.
Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome.
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.
Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
[Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification]
[Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome]
[Clinical implications of relationship between myeloperoxidase and acute coronary syndromes]
[Metabolic activity of neutrocytes and possible ways of its correction in patients with an acute coronal syndrome].
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
[Myeloperoxidase in the plasma of patients with acute coronary syndrome]
[Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
Acute Kidney Injury
Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease.
Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure.
Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation.
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
Churg-strauss syndrome presenting with acute renal insufficiency accompanied by eosinophilic tubulointerstitial nephritis.
Inflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption.
Inhibition of glycogen synthase kinase-3? attenuates acute kidney injury in sodium taurocholate?induced severe acute pancreatitis in rats.
Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy.
Microscopic polyangitis complicating double carcinoma of the stomach and duodenum: improvement after the resection of these carcinomas.
Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats.
The mechanism of myocardium and pancreas injury in rabbits with acute renal failure might be related to myeloperoxidase and membrane pump activities.
Acute Lung Injury
15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
?-Nitrostyrene derivatives attenuate LPS-mediated acute lung injury via the inhibition of neutrophil-platelet interactions and NET release.
Absinthin attenuates LPS-induced ALI through MIP-1?-mediated inflammatory cell infiltration.
Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-?B-mediated inflammatory response.
Andrographolide Sulfonate Attenuates Acute Lung Injury by Reducing Expression of Myeloperoxidase and Neutrophil-Derived Proteases in Mice.
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor.
Clinical significance of measuring myeloperoxidase, thiobarbituric acid reactive material and 7S collagen in plasma of patients with adult respiratory distress syndrome.
Critical role of IL-17RA in immunopathology of influenza infection.
Cyanidin-3-O-?-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.
Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression.
Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-beta1-Smad2 dependent pathway.
Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway.
Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury.
Formaldehyde inhalation during pregnancy abolishes the development of acute innate inflammation in offspring.
Heme Oxygenase-1 Mediates the Protective Effects of Ischemic Preconditioning on Mitigating Lung Injury Induced by Lower Limb Ischemia-Reperfusion in Rats.
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-?B-mediated inflammation.
High-altitude pulmonary edema can be prevented by heat shock protein 70-mediated hyperbaric oxygen preconditioning.
Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury.
Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
Intensive Insulin Treatment Attenuates Burn-Initiated Acute Lung Injury in Rats: Role of the Protective Endothelium.
Long-term Simvastatin Administration Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin.
Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation.
Myeloperoxidase-induced inactivation of alpha 1-antiprotease in hamsters.
Oxygenation, inflammatory response and lung injury during one lung ventilation in rabbits using inspired oxygen fraction of 0.6 vs. 1.0.
p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation.
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-?B signaling in a murine model.
Purification of myeloperoxidase from equine polymorphonuclear leucocytes.
Smart imaging of acute lung injury: exploration of myeloperoxidase activity using in vivo endoscopic confocal fluorescence microscopy.
Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13?, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury.
The involvement of nitric oxide, nitric oxide synthase, neutrophil elastase, myeloperoxidase and proinflammatory cytokines in the acute lung injury caused by phorbol myristate acetate.
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury.
Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
[Measurement of myeloperoxidase and thiobarbituric acid-reactive material in plasma and bronchoalveolar lavage in E. coli-induced acute lung injury]
Adenocarcinoma
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer.
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
Agammaglobulinemia
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
Aggressive Periodontitis
Amplified crevicular leukocyte activity in aggressive periodontal disease.
Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis.
Genetic variation of myeloperoxidase gene contributes to aggressive periodontitis: a preliminary association study in Turkish population.
Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis.
Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria.
Myeloperoxidase staining in the diagnosis of aggressive periodontitis.
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status.
Agranulocytosis
Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis.
Aminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils.
Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.
Cocaine-Induced Vasculitis.
Comparative metabolism and covalent binding of procainamide by human leukocytes.
Drug-induced protein free radical formation is attenuated by unsaturated Fatty acids by scavenging drug-derived phenyl radical metabolites.
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
Interleukin-1-induced granulocytopenia and pulmonary leukostasis in rabbits.
Involvement of Myeloperoxidase and NADPH Oxidase in the Covalent Binding of Amodiaquine and Clozapine to Neutrophils: Implications for Drug-Induced Agranulocytosis.
Peroxidase-catalysed oxidation of different dibenzazepine derivatives.
Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
Serum myeloperoxidase and lactoferrin in neutropenia.
Airway Obstruction
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
Combined recombinant human activated protein C and ceftazidime prevent the onset of acute respiratory distress syndrome in severe sepsis.
Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.
Alveolar Bone Loss
Decrease of Pericytes is Associated With Liver Disease Caused by Ligature-Induced Periodontitis in Rats.
Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats.
Effects of Melatonin on Oxidative Stress Index and Alveolar Bone Loss in Diabetic Rats With Periodontitis.
Effects of Polycan, a ?-glucan, on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats.
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
One or two ligatures inducing periodontitis are sufficient to cause fatty liver.
Orabase formulation with cashew gum polysaccharide decreases inflammatory and bone loss hallmarks in experimental periodontitis.
Periodontitis changes renal structures by oxidative stress and lipid peroxidation.
Protective effect of locally applied carvacrol gel on ligature-induced periodontitis in rats: a tapping mode AFM study.
Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: participation of endostatin and vascular endothelial growth factor.
Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats.
The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone Loss in Rats.
Alzheimer Disease
Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.
Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain.
Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene.
Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.
Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study.
Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study.
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.
No Genetic Association between the Myeloperoxidase Gene -463 Polymorphism and Estrogen Receptor-alpha Gene Polymorphisms and Japanese Sporadic Alzheimer's Disease.
Observation of the multiple halogenation of peptides in the electrospray ionization source.
Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis.
Amyloidosis
[Changes in leukocyte enzyme activity during experimental amyloidogenesis and in patients with amyloidosis]
Amyotrophic Lateral Sclerosis
Myeloperoxidase: Bridging the gap in neurodegeneration.
Anemia
Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
Churg-strauss syndrome presenting with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis.
Increased in vivo activation of neutrophils and complement in sickle cell disease.
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)).
Myeloperoxidase activity in polymorphonuclear neutrophils in nutritional anaemia.
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats.
Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice.
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
Anemia, Aplastic
Acquired myeloperoxidase deficiency of neutrophils in a patient with aplastic anemia (idiopathic marrow aplasia).
Role of myeloperoxidase index in differentiation of megaloblastic and aplastic anemia.
Anemia, Hemolytic, Autoimmune
Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.
Anemia, Iron-Deficiency
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
Anemia, Megaloblastic
Neutrophil myeloperoxidase measurement uncovers masked megaloblastic anemia.
Anemia, Refractory
Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
Quantitative iodination of human blood polymorphonuclear leukocytes.
Anemia, Sickle Cell
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
Increased in vivo activation of neutrophils and complement in sickle cell disease.
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
Inhibition of Myeloperoxidase Decreases Vascular Oxidative Stress and Increases Vasodilatation in Sickle Cell Disease Mice.
Quantitative iodination of human blood polymorphonuclear leukocytes.
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
Aneurysm
Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.
MR imaging of myeloperoxidase activity in a model of the inflamed aneurysm wall.
Myeloperoxidase in Human Intracranial Aneurysms: Preliminary Evidence.
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.
Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease.
The inflammatory response to stent grafting of the thoracic aorta.
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
Aneurysm, Ruptured
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
Angina Pectoris
KORVITIN REDUCES THE HIGH MAINTENANCE OF MYELOPEROXIDASE IN PLASMA OF BLOOD OF PATIENTS WITH THE ACUTE INFARCT OF MYOCARDIUM.
Angina, Stable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
Altered human neutrophil Fc?RI and Fc?RIII but not Fc?RII expression is associated with the acute coronary event in patients with coronary artery disease.
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
Widespread coronary inflammation in unstable angina.
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
Angina, Unstable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina.
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
Widespread coronary inflammation in unstable angina.
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
Anti-Glomerular Basement Membrane Disease
Anti-GBM disease and ANCA during dengue infection.
Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.
Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease.
AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report.
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture's syndrome: a case report and review of the literature.
Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.
[A case of Goodpasture's syndrome with myeloperoxidase specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) during chronic interstitial pneumonia]
[A case of Goodpasture's syndrome. Myeloperoxidase antibodies as a valuable serological marker in vasculitis]
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease.
Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.
Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Clinical trial for Japanese patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis: the JMAAV study.
Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies.
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
Deglycosylation influences the oxidation activity and antigenicity of myeloperoxidase.
Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
Direct and indirect pathogenic roles of autoantibodies in systemic autoimmune diseases.
Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement?
Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
Endothelial tissue factor stimulation by proteinase 3 and elastase.
Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.
Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis.
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
Remarks on the Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012.
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis.
The role of myeloperoxidase in the pathogenesis of systemic vasculitis.
Thymic Deletion and Regulatory T Cells Prevent Antimyeloperoxidase GN.
[Microscopic polyangiitis]
Antiphospholipid Syndrome
Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Anuria
An unusual presentation of antineutrophil cytoplasmic antibody-associated vasculitis: discrepancy between histopathology and clinical presentation.
Aortic Aneurysm, Abdominal
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
Aortic Valve Stenosis
Aortic valve replacement in a patient with MPO-ANCA-positive Goodpasture disease.
Myeloperoxidase and progression of aortic valve stenosis in patients undergoing hemodialysis.
Aortitis
Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
Apnea
Hypoxia/reoxygenation and vitamin C intake influence NO synthesis and antioxidant defenses of neutrophils.
Appendicitis
Can new inflammatory markers improve the diagnosis of acute appendicitis?
Composition of the cellular infiltrate in patients with simple and complex appendicitis.
The Use of Delta Neutrophil Index and Myeloperoxidase Index for Predicting Acute Complicated Appendicitis in Children.
Arteriosclerosis
[Myeloperoxidase activity in patients with complicated arteriosclerosis and in their relatives]
[Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis]
Arteriovenous Fistula
Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas.
Arteriovenous Malformations
Evidence of inflammatory cell involvement in brain arteriovenous malformations.
Arteritis
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy.
Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.
Arthralgia
Cocaine-Induced Vasculitis.
Arthritis
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis.
Antinociceptive and antidepressant-like effects of the crude extract of Vitex megapotamica in rats.
Combination of carvacrol with methotrexate suppresses Complete Freund's Adjuvant induced synovial inflammation with reduced hepatotoxicity in rats.
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis.
Immunomodulatory and anti-inflammatory effects of Semecarpus anacardium LINN. Nut milk extract in experimental inflammatory conditions.
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
Is Taurolidine a candidate for treatment of rheumatoid arthritis?
Kupffer-cell depletion attenuates colonic and extracolonic granulomatous inflammation in chronic colitis.
Melatonin is a potent inhibitor for myeloperoxidase.
Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis.
Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis.
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase.
Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model.
Scientific validation of Anti-arthritic effect of Kashayams - a polyherbal formulation in collagen induced arthritic rats.
The Impacts of Chrysanthemum indicum Extract on Oxidative Stress and Inflammatory Responses in Adjuvant-Induced Arthritic Rats.
Arthritis, Experimental
Bis(phenylimidazoselenazolyl) diselenide elicits antinociceptive effect by modulating myeloperoxidase activity, NOx and NFkB levels in the collagen-induced arthritis mouse model.
Clitoria ternatea flower petals: Effect on TNFR1 neutralization via downregulation of synovial matrix metalloproteases.
Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil.
Arthritis, Juvenile
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
Arthritis, Psoriatic
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation.
Arthritis, Reactive
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
Arthritis, Rheumatoid
Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis.
Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass.
Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis.
Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis.
Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.
Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.
Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis.
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation.
Clinical proteomics in chronic inflammatory diseases: A review.
Direct and indirect pathogenic roles of autoantibodies in systemic autoimmune diseases.
Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients.
High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.
Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis.
Increased myeloperoxidase plasma levels in rheumatoid arthritis.
Inhibition of myeloperoxidase by synovial fluid and serum.
Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
Methods for measuring myeloperoxidase activity toward assessing inhibitor efficacy in living systems.
Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis.
Myeloperoxidase and oxidative stress in rheumatoid arthritis.
Myeloperoxidase deficiency in a patient with rheumatoid arthritis: oxygenation and radical activity by phagocytic cells.
NMR studies on human, pathologically changed synovial fluids: role of hypochlorous acid.
Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue.
Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report.
Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis.
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
The effect of D-penicillamine on human myeloperoxidase, a mechanism for the efficacy of the drug in rheumatoid arthritis.
The effect of D-penicillamine on myeloperoxidase: formation of compound III and inhibition of the chlorinating activity.
The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species.
[Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases]
[The cytochemical characteristics of neutrophilic leukocytes in the peripheral blood and synovial fluid of patients with rheumatoid arthritis in the course of treatment]
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
Arthus Reaction
Immune complexes and inflammation. A study of the activity of anti-inflammatory drugs in the reverse passive arthus reaction in the rat.
Asbestosis
Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
Ascorbic Acid Deficiency
Phagocytosis and leukocyte enzymes in ascorbic acid deficient guinea pigs.
Aspergillosis
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
Asthma
A Role of the ABCC4 Gene Polymorphism in Airway Inflammation of Asthmatics.
A testing framework for identifying susceptibility genes in the presence of epistasis.
Adenosine as a Modulator of Functional Activity of Peripheral Blood Phagocytes in Asthmatic Patients and Healthy Volunteers.
Adiponectin alleviates exacerbation of airway inflammation and oxidative stress in obesity-related asthma mice partly through AMPK signaling pathway.
Assessment of serum myeloperoxidase in children with bronchial asthma.
Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma.
Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association.
Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.
Bronchoalveolar lavage in asthmatic children: evidence of neutrophil activation in mild-to-moderate persistent asthma.
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
Cough, airway inflammation, and mild asthma exacerbation.
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
Effect of Antibiotics on Polymorphonuclear Leukocyte Functions and Myeloperoxidase Activity, Glutathione and Malondialdehyde Levels in Allergic Asthma.
Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients.
Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy.
Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis.
Formation of reactive sulfite-derived free radicals by the activation of human neutrophils: An ESR study.
Functional variants in the catalase and myeloperoxidase genes, ambient air pollution, and respiratory-related school absences: an example of epistasis in gene-environment interactions.
Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.
Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Inflammatory Pattern of the Bronchial Mucosa in Patients with Asthma with Airway Hyperresponsiveness to Hypoosmotic Stimulus.
Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease.
Iron, nitric oxide, and myeloperoxidase in asthmatic patients.
Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
Markers of airway inflammation in preschool wheezers.
Melatonin is a potent inhibitor for myeloperoxidase.
Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1.
Neutrophilic inflammation in severe persistent asthma.
Oxidative and nitrosative events in asthma.
Participation of Antidiuretic Hormone (ADH) in Asthma Exacerbations Induced by Psychological Stress via PKA/PKC Signal Pathway in Airway-Related Vagal Preganglionic Neurons (AVPNs).
Plasma protein leakage and local secretion of proteins assessed in sputum in asthma and COPD. The effect of inhaled corticosteroids.
Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.
Relationship between cough, cough receptor sensitivity and asthma in children.
Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction.
Serum inflammatory markers and effects of age and tobacco smoke exposure in young non-asthmatic children.
Serum levels of eosinophilic cationic protein (ECP), myeloperoxidase (MPO), lipid peroxidation products, interleukin (IL)-5 and interferon (IFN)-gamma in children with bronchial asthma at acute asthma attack and remission.
Serum myeloperoxidase in wheezing infants: no association with later asthma.
Stimulated salivary flow rate and composition in asthmatic and non-asthmatic adults.
Sulfite-mediated oxidation of myeloperoxidase to a free radical: Immuno-spin trapping detection in human neutrophils.
Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment.
[A case of Churg-Strauss syndrome with short duration from the onset of asthma to diagnosis of vasculitis].
Ataxia Telangiectasia
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
Atherosclerosis
A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages.
A pivotal role for NF-?B in the macrophage inflammatory response to the myeloperoxidase oxidant hypothiocyanous acid.
A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL.
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency.
Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study.
Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes.
Association between myeloperoxidase levels and risk of coronary artery disease.
Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
Association of myeloperoxidase with cardiovascular disease risk factors in prediabetic subjects.
Atherosclerosis and oxidative stress.
Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction.
Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum.
Bioluminescence imaging of myeloperoxidase activity in vivo.
Biosynthesis, processing, and sorting of human myeloperoxidase.
Chlorinative stress in age-related diseases: a literature review.
Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes.
Cocoa polyphenols and inflammatory mediators.
Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis.
Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation.
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.
Development of an ELISA for myeloperoxidase on microplate: Normal reference values and effect of temperature on specimen preparation.
Development of Monoclonal Antibody against Chlorinated 192 Tyrosine Containing ApoAI Peptide to Screen Quality of Human High Density Lipoprotein (HDL).
Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase.
Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction.
Does mercury promote lipid peroxidation? An in vitro study concerning mercury, copper, and iron in peroxidation of low-density lipoprotein.
Dysfunctional high-density lipoprotein.
Effect of inhibitors of myeloperoxidase on the development of aortic atherosclerosis in an animal model.
Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase promoter polymorphism.
Effect of unsaturation in fatty acids on the binding and oxidation by myeloperoxidase: ramifications for the initiation of atherosclerosis.
Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.
Effects of hypochlorite and hydrogen peroxide on cardiac autonomic receptors and vascular endothelial function.
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques.
Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes.
Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice.
Generation of intramolecular and intermolecular sulfenamides, sulfinamides, and sulfonamides by hypochlorous acid: a potential pathway for oxidative cross-linking of low-density lipoprotein by myeloperoxidase.
Heparin, myeloperoxidase, and atherosclerosis: a new focus on an old drug.
High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase.
High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine.
Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis.
Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I.
Humans with Atherosclerosis have Impaired ABCA1 Cholesterol Efflux and Enhanced HDL Oxidation by Myeloperoxidase.
Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival.
Hypochlorous acid-modified extracellular matrix contributes to the behavioral switching of human coronary artery smooth muscle cells.
Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.
In vivo examination of 111In-bis-5HT-DTPA to target myeloperoxidase in atherosclerotic ApoE knockout mice.
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Inhibition of myeloperoxidase might be a novel therapeutic target in the treatment of atherosclerosis.
Kinetics of chlorination of monochlorodimedone by myeloperoxidase.
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.
Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders.
Melatonin is a potent inhibitor for myeloperoxidase.
Metabolism of myeloperoxidase-derived 2-chlorohexadecanal.
MPO and neutrophils: a magnetic attraction.
Myeloperoxidase activity imaging using (67)Ga labeled substrate.
Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis.
Myeloperoxidase derived oxidants damage artery wall proteins in an animal model of chronic kidney disease accelerated atherosclerosis.
Myeloperoxidase gene variation as a determinant of atherosclerosis progression in the abdominal and thoracic aorta: an autopsy study.
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.
Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome.
Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol.
Myeloperoxidase Production by Macrophage and Risk of Atherosclerosis.
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
Myeloperoxidase, modified lipoproteins, and atherogenesis.
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.
Myeloperoxidase-derived 2-chlorohexadecanal forms Schiff bases with primary amines of ethanolamine glycerophospholipids and lysine.
Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.
Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein.
Myeloperoxidase: A promising therapeutic target in prevention of atherosclerosis.
Neutrophil elastase and myeloperoxidase mRNA expression in overweight and obese subjects.
Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
Niacin decreases leukocyte myeloperoxidase: mechanistic role of redox agents and Src/p38MAP kinase.
Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein.
Novel biomarkers in cardiovascular disease: update 2010.
Oenothera paradoxa defatted seeds extract and its bioactive component penta-O-galloyl-?-D-glucose decreased production of reactive oxygen species and inhibited release of leukotriene B4, interleukin-8, elastase, and myeloperoxidase in human neutrophils.
Oxidative modification of low-density lipoprotein: lipid peroxidation by myeloperoxidase in the presence of nitrite.
Paraoxonase 1 and HDL maturation.
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial.
Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS.
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity.
Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate.
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Prognostic value of plasma myeloperoxidase in ESRD patients.
Protective effects of Xiongshao Capsule () on anti-inflammatory function of high-density lipoprotein in atherosclerosis rabbit model.
Protein thiol oxidation and formation of S-glutathionylated cyclophilin A in cells exposed to chloramines and hypochlorous acid.
Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study.
Radical acetoacetate oxidation by myeloperoxidase, lactoperoxidase, prostaglandin synthetase, and prostacyclin synthetase: implications for atherosclerosis.
Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis.
Serial Analyses of C-Reactive Protein and Myeloperoxidase in Acute Coronary Syndrome.
Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.
Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis.
Serum myeloperoxidase is independent of the risk factors of atherosclerosis.
Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: a marker of atherosclerosis in patients with normal cholesterol levels.
Targeting myeloperoxidase in inflammatory atherosclerosis.
The ARIC Carotid MRI Study of Blood Cellular Markers: An Inverse Association of Monocyte Myeloperoxidase Content With Peripheral Arterial Disease.
The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected.
The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands.
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.
The presence of modified nucleosides in extracellular fluids leads to the specific incorporation of 5-chlorocytidine into RNA and modulates the transcription and translation.
The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.
The role of myeloperoxidase in HDL oxidation and atherogenesis.
The role of myeloperoxidase in the pathogenesis of coronary artery disease.
The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
The use of myeloperoxidase as a risk marker for atherosclerosis.
Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
Therapeutic Potential of Ocimum tenuiflorum as MPO Inhibitor with Implications for Atherosclerosis Prevention.
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.
Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure.
Validation of a sensitive LC/MSMS method for chloronucleoside analysis in biological matrixes and its applications.
Vitamin C protects against hypochlorous Acid-induced glutathione depletion and DNA base and protein damage in human vascular smooth muscle cells.
[Indicators of lipid peroxidation in the blood in hereditary predisposition to arteriosclerosis]
[Markers of chloric acid (I) in biological systems--identification and properties].
[Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis]
[Role of protein carbamylation in chronic kidney disease complications].
Atrial Fibrillation
Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing.
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.
Myeloperoxidase and risk of recurrence of atrial fibrillation after catheter ablation.
The onset of Graves' disease during the clinical course of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis.
Autoimmune Diseases
Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat.
Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride.
Brother and sister with myeloperoxidase associated autoimmune disease.
Discrepancies between two immunoassays for the determination of MPO and PR3 autoantibodies.
Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angiitis.
The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodies.
Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.
Bacteremia
Fms-Like Tyrosine Kinase-3 Ligand Attenuates Local and Systemic Infection in a Model of Post-Burn Pneumonia.
IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia.
Reduced neutrophil sequestration in lung tissue after laparoscopic lavage in a rat peritonitis model.
The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
Bacterial Infections
A1M/?1-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation.
Association between the neutrophil myeloperoxidase index and subsets of bacterial infections.
cDNA cloning and gene expression pattern following bacterial challenge of peroxinectin in Chinese shrimp Fenneropenaeus chinensis.
Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats.
Fishmeal replacement by rice protein concentrate with xylooligosaccharides supplement benefits the growth performance, antioxidant capability and immune responses against Aeromonas hydrophila in blunt snout bream (Megalobrama amblycephala).
Lipoprotein-associated phospholipase A2, myeloperoxidase and vascular endothelial growth factor - predictors of high vascular risk in respiratory bacterial infections.
Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins.
Neutrophil dysfunction and increased susceptibility to infection.
Neutrophil myeloperoxidase concentration: changes with development and during bacterial infection.
Neutrophilic granulocytes in acute bacterial infection. Sequential studies on lysozyme, myeloperoxidase and lactoferrin.
Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease.
The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections.
The influence of intravenous anaesthetics on polymorphonuclear leukocyte function.
Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.
Barrett Esophagus
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
Blast Crisis
Cytophotometry of granulocytes in chronic granulocytic leukemia patients. Part I. Cell cycle distribution, S-phase transition and quantitative cytochemistry.
Eosinophilic blast crisis in a case of chronic myeloid leukaemia.
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes.
Hybrid lymphoid blast crisis of chronic myeloid leukemia with both immunoglobulin and T-cell receptor gene rearrangements.
Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Ultrastructural study of chronic myeloid leukemia in blast crisis using myeloperoxidase and acid phosphatase reactions.
Blister
8;21 Translocation in acute myeloid leukemia. An ultrastructural study.
Evaluation of the effect of azapropazone on neutrophil migration in anaesthetized swine using a multichamber blister suction technique.
Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.
Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
Inhibitory effect of KBT-3022, a new anti-platelet agent, on infiltration of polymorphonuclear leukocytes induced by leukotriene B4 or formyl-methionyl-leucyl-phenylalanine in mice.
Marked hyperphosphatasemia associated with an acute leukemia in a Great Dane.
Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity.
Bone Resorption
The effect of dichloromethylene bisphosphonate on human gingival crevicular neutrophil myeloperoxidase activity.
Therapeutic Effects of Melatonin on Alveolar Bone Resorption After Experimental Periodontitis in Rats: A Biochemical and Immunohistochemical Study.
Brain Abscess
The proteome of pus from human brain abscesses: host-derived neurotoxic proteins and the cell-type diversity of CNS pus.
Brain Death
Amelioration of renal damage by administration of anti-thymocyte globulin to potential donors in a brain death rat model.
Brain Diseases
Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.
Brain Edema
Attenuation of brain inflammatory response after focal cerebral ischemia/reperfusion with xuesaitong injection in rats.
Changes of MPO activity and brain water accumulation in traumatic brain injury experiments.
Effect of Rosiglitazone Maleate on inflammation following cerebral ischemia/reperfusion in rats.
Inhibition of leukotriene B4 synthesis protects against early brain injury possibly via reducing the neutrophil-generated inflammatory response and oxidative stress after subarachnoid hemorrhage in rats.
MRI of Iron Oxide Nanoparticles and Myeloperoxidase Activity Links Inflammation to Brain Edema in Experimental Cerebral Malaria.
Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury.
Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury.
Recombinant Netrin-1 binding UNC5B receptor attenuates neuroinflammation and brain injury via PPAR?/NF?B signaling pathway after subarachnoid hemorrhage in rats.
Reduced brain injury in CD18-deficient mice after experimental intracerebral hemorrhage.
Brain Infarction
AP-VAS 2012 case report: a case of systemic MPO-ANCA-associated vasculitis that demonstrated brain infarction and immunohistochemically MPO-positive capillaries.
Ethanol attenuates ischemic and hypoxic injury in rat brain and cultured neurons.
Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome.
NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
Rosmarinic acid prevents against memory deficits in ischemic mice.
Brain Injuries
Changes of MPO activity and brain water accumulation in traumatic brain injury experiments.
Decreased myeloperoxidase expressing cells in the aged rat brain after excitotoxic damage.
Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain.
Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model.
Hyperglycemia triggers massive neutrophil deposition in brain following transient ischemia in rats.
Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury.
Inhibition of Myeloperoxidase by
Transplantation of human amniotic mesenchymal stem cells promotes neurological recovery in an intracerebral hemorrhage rat model.
Brain Injuries, Traumatic
AA-861 appears to suppress leukocyte infiltration induced by traumatic brain injury in rats.
Importance of posttraumatic hypothermia and hyperthermia on the inflammatory response after fluid percussion brain injury: biochemical and immunocytochemical studies.
Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models.
Brain Ischemia
(-)-?-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice.
5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.
Anti-inflammatory effect of hydroxyethylpuerarin on focal brain ischemia/reperfusion injury in rats.
Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism.
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury.
Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury.
Ischemic preconditioning reduces ischemic brain injury by suppressing nuclear factor kappa B expression and neuronal apoptosis.
Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia.
Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.
Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity.
Propofol Reduces Inflammatory Reaction and Ischemic Brain Damage in Cerebral Ischemia in Rats.
Protective effects of melatonin in ischemic brain injury.
Repetitive Ischemic Preconditioning Attenuates Inflammatory Reaction and Brain Damage After Focal Cerebral Ischemia in Rats: Involvement of PI3K/Akt and ERK1/2 Signaling Pathway.
Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase.
Breast Neoplasms
Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk.
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
Luminol-based bioluminescence imaging of mouse mammary tumors.
Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysis.
Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk.
Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897.
Myeloperoxidase polymorphism, menopausal status, and breast cancer risk: an update meta-analysis.
N-acetylglucosaminidase, myeloperoxidase and vascular endothelial growth factor serum levels in breast cancer patients.
Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.
Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk.
Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer.
The role of peroxidase-catalyzed activation of aromatic amines in breast cancer.
[The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients after surgery]
[The plasma level of sL-selectin, myeloperoxidase and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients in the course of chemotherapy]
Bronchial Diseases
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation.
Bronchial Hyperreactivity
Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.
Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse.
Bronchiectasis
Blood Neutrophils Are Reprogrammed in Bronchiectasis.
Bronchial inflammation and colonization in patients with clinically stable bronchiectasis.
Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody.
Clinical phenotypes in adult patients with bronchiectasis.
Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation.
Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.
Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: green is not good.
[Functional activity of the neutrophils in the bronchoalveolar space in chronic bronchitis and bronchiectasis]
Bronchiolitis
Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products.
Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy.
Relationship between atopic status and nasal interleukin 10 and 11 levels in infants with respiratory syncytial virus bronchiolitis.
Bronchitis
Development of a functional point-of-need diagnostic for myeloperoxidase detection to identify neutrophilic bronchitis.
Increased serum inflammatory markers as predictors of airway obstruction.
Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation?
Bronchitis, Chronic
Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid.
Effect of bacterial extract, IRS-19, on the concentration of hydrogen peroxide and myeloperoxidase activity in nasal washings of patients with chronic bronchitis.
Sex differences in reported and objectively measured sleep in COPD.
[A study on tumor necrosis factor alpha, macrophage inflammatory protein-2 and myeloperoxidase in blood, broncho-alveolar fluid and lung tissues of rat chronic bronchitis model]
[Effects of bacterial extract IRS-19 on the concentration of hydrogen peroxide and myeloperoxidase activity in nasal washings of patients with chronic bronchitis]
[Functional activity of the neutrophils in the bronchoalveolar space in chronic bronchitis and bronchiectasis]
Bronchopneumonia
Bronchoalveolar lavage fluids of patients with lung injury activate the transcription factor nuclear factor-kappaB in an alveolar cell line.
Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines.
The involvement of polymorphonuclear leukocytes in the pathogenesis of bronchopneumonia in calves. IV. Myeloperoxidase activity.
Bronchopulmonary Dysplasia
Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia.
Bronchopulmonary Sequestration
Prevention of ischemia-reperfusion lung injury by sulfated Lewis(a) pentasaccharide. The Paris-Sud University Lung Transplantation Group.
Pulmonary damage by Vibrio vulnificus cytolysin.
The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin.
Brucellosis
Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis.
[Functional and metabolic activity of leukocytes in patients with chronic brucellosis]
[The functional metabolic activity of the blood neutrophils in different clinical forms of brucellosis]
Candidiasis
Candidacidal activity of myeloperoxidase: therapeutic influence of the enzyme in vivo.
Fungal infections in primary immunodeficiencies.
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.
Myeloperoxidase deficiency as a predisposing factor for deep mucocutaneous candidiasis: a case report.
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
[The phagocytic activity of the neutrophilic granulocytes in patients with chronic candidiasis of the skin and mucous membranes]
Candidiasis, Chronic Mucocutaneous
Fungal infections in primary immunodeficiencies.
Candidiasis, Invasive
Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor.
Candidiasis, Oral
Elevation of myeloperoxidase activity in infants with oral candidiasis treated with clotrimazole.
Myeloperoxidase deficiency associated with atypical oral candidiasis: A clinical report.
Candidiasis, Vulvovaginal
Propolis increases neutrophils response against Candida albicans through the increase of reactive oxygen species.
Carcinogenesis
A myeloperoxidase polymorphism associated with reduced risk of lung cancer.
Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
Benzene Metabolite, 1,2,4-Benzenetriol, Induces Halogenated DNA and Tyrosines Representing Halogenative Stress in Human Myeloid Cell Line HL-60.
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis.
Formation of acrolein-derived 2'-deoxyadenosine adduct in an iron-induced carcinogenesis model.
Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
Myeloperoxidase activity and whole blood chemiluminescence in bladder cancer--influence of smoking.
Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis.
Myeloperoxidase-induced genomic DNA-centered radicals.
RAMP1 Is a Direct NKX3.1 Target Gene Up-Regulated in Prostate Cancer that Promotes Tumorigenesis.
Role of the Vanins-Myeloperoxidase Axis in Colorectal Carcinogenesis.
The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies.
Carcinoma
Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma.
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma.
Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas.
Second primary tumors and myeloperoxidase expression in buccal mucosal squamous cell carcinoma.
The activity of neutrophil myeloperoxidase in patients with lung carcinoma.
The association between immunoexpression levels of oxidant and antioxidant enzymes and lip squamous cell carcinoma.
Carcinoma, Hepatocellular
A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
Plasma myeloperoxidase levels correlate with hepatocellular carcinoma in chronic hepatitis C.
Carcinoma, Intraductal, Noninfiltrating
Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
Carcinoma, Non-Small-Cell Lung
Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.
Carcinoma, Ovarian Epithelial
Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer.
Carcinoma, Squamous Cell
Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma.
Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas.
Second primary tumors and myeloperoxidase expression in buccal mucosal squamous cell carcinoma.
The association between immunoexpression levels of oxidant and antioxidant enzymes and lip squamous cell carcinoma.
Cardiomyopathies
Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function.
Cardiotoxicity
Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.
Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
Melatonin protects against ischemic heart failure in rats.
The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats.
The role of cardiac biomarkers in cardio-oncology.
Update on Incorporating Biomarkers with Imaging Findings for the Detection and Management of Cardiotoxicity.
Cardiovascular Diseases
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients.
A novel multistep mechanism for oxygen binding to ferrous hemoproteins: rapid kinetic analysis of ferrous-dioxy myeloperoxidase (compound III) formation.
A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma.
Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function.
Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study.
Alterations of HDL Particles in Children with End-stage Renal Disease.
Assessment of oxidative stress and inflammation in prediabetes-A hospital based cross-sectional study.
Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
Association of myeloperoxidase with cardiovascular disease risk factors in prediabetic subjects.
B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjects.
Cross-sectional correlates of myeloperoxidase and alpha-1-acid glycoprotein with adiposity, atherogenic and hematological indices in metabolic syndrome patients with or without diabetes.
Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay.
Developing and assessing cardiovascular biomarkers.
Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction.
Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor.
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases.
Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients.
Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations.
Effects of selenium supplementation on paraoxonase-1 and myeloperoxidase activity in subjects with cardiovascular disease: the Selenegene study, a double-blind randomized controlled trial.
Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO.
Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites.
High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair.
Hyperglycemia and Oxidative Stress Strengthen the Association Between Myeloperoxidase and Blood Pressure.
Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor.
Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.
Iridium oxide nanomonitors: Clinical diagnostic devices for health monitoring systems.
Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach.
Levels of Nitric Oxide Metabolites and Myeloperoxidase in Subjects with Type 2 Diabetes Mellitus on Metformin Therapy?.
Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia.
Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
Mesna (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase.
Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.
Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
Myeloperoxidase - a leukocyte-derived protagonist of inflammation and cardiovascular disease.
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
Myeloperoxidase and cardiovascular disease.
Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.
Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Myeloperoxidase evokes substantial vasomotor responses in isolated skeletal muscle arterioles of the rat.
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Myeloperoxidase in cardiovascular disease.
Myeloperoxidase in chronic kidney disease.
Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Myeloperoxidase Is an Early Biomarker of Inflammation and Cardiovascular Risk in Prepubertal Obese Children.
Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemia.
Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.
Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease.
Nanomonitors: electrical immunoassays for protein biomarker profiling.
Neutrophil elastase and myeloperoxidase mRNA expression in overweight and obese subjects.
Neutrophil myeloperoxidase and its substrates: formation of specific markers and reactive compounds during inflammation.
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
Novel biomarkers of cardiovascular disease: myeloperoxidase for acute and/or chronic heart failure?
Oenothera paradoxa defatted seeds extract and its bioactive component penta-O-galloyl-?-D-glucose decreased production of reactive oxygen species and inhibited release of leukotriene B4, interleukin-8, elastase, and myeloperoxidase in human neutrophils.
Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress.
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.
Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans.
Prognostic value of myeloperoxidase in patients with chest pain.
Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD).
Roles of myeloperoxidase and GAPDH in interferon-gamma production of GM-CSF-dependent macrophages.
Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.
Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.
The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD).
Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome.
Urate as a Physiological Substrate for Myeloperoxidase: IMPLICATIONS FOR HYPERURICEMIA AND INFLAMMATION.
Carotid Artery Diseases
Association of myeloperoxidase gene variation with carotid atherosclerosis in patients with essential hypertension.
Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia.
Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol.
The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
Carotid Stenosis
Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol.
catalase deficiency
Catalase deficiency in myeloperoxidase deficient polymorphonuclear leucocytes from chicken.
Catalepsy
Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Cataract
[Characteristics of chloramine complexes of carnosine with hypochlorite anion]
[The role of myeloperoxidase, a product of the polymorphonuclear leukocytes, in the pathogenesis of cataract]
Cerebral Hemorrhage
Serum myeloperoxidase concentrations for outcome prediction in acute intracerebral hemorrhage.
Cerebral Infarction
Resveratrol alleviates nerve injury after cerebral ischemia and reperfusion in mice by inhibiting inflammation and apoptosis.
The anti-inflammatory effect of paeoniflorin on cerebral infarction induced by ischemia-reperfusion injury in Sprague-Dawley rats.
Cerebral Palsy
Association of cord blood cytokines with prematurity and cerebral palsy.
Cerebral Small Vessel Diseases
Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke.
Cerebrovascular Disorders
Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke.
New biochemical markers in acute coronary syndromes.
Chagas Disease
Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease.
Inactivation of Trypanosoma cruzi dihydrolipoamide dehydrogenase by leukocyte myeloperoxidase systems: role of hypochloride and nitrite related radicals.
Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.
Chediak-Higashi Syndrome
Biochemical studies on the leukocytes in Chediak-Higashi syndrome.
Congenital disorders of the function of polymorphonuclear neutrophils.
Defective polymorphonuclear leukocyte metabolism and function in canine cyclic neutropenia.
Neutrophil function studies in clinical medicine.
Normal-sized primary lysosomes are present in Chediak-Higashi syndrome neutrophils.
Phagocyte defects.
[Hereditary polymorphonuclear neutrophil deficiencies]
Cheilitis
Noma-like gangrenous cheilitis in a child with cyclic neutropenia associated with myeloperoxidase deficiency.
Cholangitis, Sclerosing
Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
Cholecystitis
Interleukin-1 mediates guinea pig gallbladder inflammation in vivo.
The effect of capsaicin on gallbladder fluid absorption.
The production of experimental cholecystitis by endotoxin.
The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor.
Cholecystitis, Acute
[Functional-metabolic activity of leukocytes in patients with cholecystitis]
Cholera
Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum.
Cholestasis
Protective Effect of Brazilian Propolis against Liver Damage with Cholestasis in Rats Treated with ?-Naphthylisothiocyanate.
Cholesteatoma
Is there a relationship between myeloperoxidase activity and conductive hearing loss in chronic otitis media complicated by cholesteatoma?
Chorioamnionitis
Amniotic fluid myeloperoxidase in pregnancies complicated by preterm prelabor rupture of membranes.
Persistence after birth of systemic inflammation associated with umbilical cord inflammation.
Surfactant Components and Tracheal Aspirate Inflammatory Markers in Preterm Infants with Respiratory Distress Syndrome.
Chronic Periodontitis
Aggressive periodontitis: An appraisal of systemic effects on its etiology-genetic aspect.
Amplified crevicular leukocyte activity in aggressive periodontal disease.
Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study.
Evaluation of Systemic Levels of Neutrophilic Enzymes in Hypertensive Patients With Chronic Periodontitis.
Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy.
Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis.
Myeloperoxidase activity in peripheral blood, neutrophil crevicular fluid and whole saliva of patients with periodontal disease.
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis.
The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status.
Churg-Strauss Syndrome
A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.
Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Autoantibodies in vasculitis.
Churg-strauss syndrome presenting with acute renal insufficiency accompanied by eosinophilic tubulointerstitial nephritis.
Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
Pathogenesis of PR3-ANCA associated vasculitis.
Pathophysiology of ANCA-associated small vessel vasculitis.
Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma.
Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.
Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology.
TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.
[Antineutrophil cytoplasmic antibodies--ANCA]
[Autoantibodies associated with vasculitis]
[Classification of systemic vasculatides]
[Clinical study on five myeloperoxidase specific anti-neutrophil cytoplasmic antibody (MPO-ANCA) positive Churg-Strauss syndrome cases]
[Microscopic polyangiitis]
Coinfection
Enteroaggregative E. coli Subclinical Infection and co-Infections and Impaired Child Growth in the MAL-ED Cohort Study.
Enteroaggregative Escherichia coli Subclinical Infection and Coinfections and Impaired Child Growth in the MAL-ED Cohort Study.
Colic
Assessment of systemic inflammation by time-trends of blood granulocyte count and plasma myeloperoxidase and elastase concentrations following colic surgery in horses.
Colitis
1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization.
?-Mangostin ameliorates dextran sulfate sodium-induced colitis through inhibition of NF-?B and MAPK pathways.
A budesonide prodrug accelerates treatment of colitis in rats.
A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression.
A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles.
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.
A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production.
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.
Acetic acid-derived prostaglandin-dependent colonic adaptive cytoprotection is preserved in chronic colitis: role of cyclo-oxygenase.
Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506.
Activation of colo-rectal high-threshold afferent nerves by Interleukin-2 is tetrodotoxin-sensitive and upregulated in a mouse model of chronic visceral hypersensitivity.
Activation of toll-like receptor 3 protects against DSS-induced acute colitis.
Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis.
Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.
Acute murine colitis reduces colonic 5-aminosalicylic acid metabolism by regulation of N-acetyltransferase-2.
Adeno-associated virus-mediated colonic secretory expression of HMGB1 A box attenuates experimental colitis in mice.
All-trans retinoic acid attenuates experimental colitis through inhibition of NF-?B signaling.
Altered expression of the Na+/H+ exchanger isoform-3 in experimental colitis: effect of garlic.
Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor-kappab decoy oligonucleotides.
Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor.
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.
An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis.
An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis.
Angiopoietin-2 in experimental colitis.
Antagonism of protease-activated receptor 2 protects against experimental colitis.
Anti-inflammatory Actions of (+)-3'?-Angeloxy-4'-keto-3',4'-dihydroseselin (Pd-Ib) against Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice.
Anti-inflammatory activity of hydroalcoholic extracts of Lavandula dentata L. and Lavandula stoechas L.
Anti-inflammatory effect of acute stress on experimental colitis is mediated by cholecystokinin-B receptors.
Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.
Anti-inflammatory effect of Euphorbia supina extract in dextran sulfate sodium-induced colitis mice.
Anti-inflammatory effect of kaurenoic acid, a diterpene from Copaifera langsdorffi on acetic acid-induced colitis in rats.
Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats.
Anti-Inflammatory Effects of Fargesin on Chemically Induced Inflammatory Bowel Disease in Mice.
Anti-inflammatory Effects of Flavonoids on TNBS-induced Colitis of Rats.
Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.
Anti-inflammatory effects of nesfatin-1 in rats with acetic acid - induced colitis and underlying mechanisms.
Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice.
Antiinflammatory effects of Cordia myxa fruit on experimentally induced colitis in rats.
Antiinflammatory effects of human milk on chemically induced colitis in rats.
Antisense inhibition of cyclooxygenase-2 causes a selective suppression of the Na+-H+ exchanger isoform 3 in rat kidney in experimental colitis.
Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: Towards a novel treatment strategy in colitis.
Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-?? activation.
Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice.
Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with ?-linolenic acid in a rat model of inflammatory bowel disease.
Attenuation of epithelial injury in acute experimental colitis by immunomodulators.
Augmented reduction in colonic inflammatory markers of dextran sulfate sodium-induced colitis with a combination of 5-aminosalicylic acid and AD-lico™ from Glycyrrhiza inflata.
Azadirachta indica Attenuates Colonic Mucosal Damage in Experimental Colitis Induced by Trinitrobenzene Sulfonic Acid.
Bacterial peptides enhance inflammatory activity in a rat model of colitis.
Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in mice.
Beneficial Effect of Herbal Formulation KM1608 on Inflammatory Bowl Diseases: A Preliminary Experimental Study.
Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
Beneficial effects of local or systemic lidocaine in experimental colitis.
Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats.
Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats.
Beneficial effects of ropivacaine in rat experimental colitis.
Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats.
Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice.
Blood flow alterations in TNBS-induced colitis: role of endothelin receptors.
Blood purine and energy status in rats with colitis.
Brugia malayi abundant larval transcript 2 protein treatment attenuates experimentally-induced colitis in mice.
Brugia malayi cystatin therapeutically ameliorates dextran sulfate sodium-induced colitis in mice.
BTZO-15, an ARE-Activator, Ameliorates DSS- and TNBS-Induced Colitis in Rats.
Calprotectin protects against experimental colonic inflammation in mice.
Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway.
Changes in urinary bladder smooth muscle function in response to colonic inflammation.
Chemical characterization and anti-inflammatory effect of rauvolfian, a pectic polysaccharide of Rauvolfia callus.
Chitosan/Kollicoat SR 30D film-coated pellets of aminosalicylates for colonic drug delivery.
Citrobacter rodentium colitis evokes post-infectious hyperexcitability of mouse nociceptive colonic dorsal root ganglion neurons.
Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.
Clinical relevance of oxygen radicals in inflammatory bowel disease--facts and fashion.
Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-kappaB-dependent manner.
Colitis affects the smooth muscle and neural response to motilin in the rabbit antrum.
Colitis-induced oxidative damage of the colon and skeletal muscle is ameliorated by regular exercise in rats: the anxiolytic role of exercise.
Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
Colonic inflammation in the rabbit induced by phorbol-12-myristate-13-acetate.
Colonic ulceration and increase of neutrophil elastase activity in the acetic acid-induced colitis model in Syrian hamsters.
Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid.
Complement component 6 deficiency increases susceptibility to dextran sulfate sodium-induced murine colitis.
Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.
Contribution of dipeptidyl peptidase IV to the severity of dextran sulfate sodium-induced colitis in the early phase.
Copaiba oil decreases oxidative stress and inflammation but not colon damage in rats with TNBS-induced colitis.
Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice.
Curative effect of Terminalia chebula extract on acetic acid-induced experimental colitis: role of antioxidants, free radicals and acute inflammatory marker.
Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis.
Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-?B signaling pathway.
Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis.
CYP4F18-Deficient Neutrophils Exhibit Increased Chemotaxis to Complement Component C5a.
Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis.
Decreased drug penetration in inflamed tissue related to changed mucosal metabolism in experimental colitis.
Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis.
Design and evaluation of acrylate polymeric carriers for fabrication of pH-sensitive microparticles.
Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.
Dietary flaxseed intake exacerbates acute colonic mucosal injury and inflammation induced by dextran sodium sulfate.
Dietary glycine prevents chemical-induced experimental colitis in the rat.
Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats.
Dietary Nondigestible Polysaccharides Ameliorate Colitis by Improving Gut Microbiota and CD4+ Differentiation, as Well as Facilitating M2 Macrophage Polarization.
Dietary taurine attenuates dextran sulfate sodium (DSS)-induced experimental colitis in mice.
Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
Dual effects of a high-protein diet on DSS-treated mice during colitis resolution phase.
Effect of a novel water-soluble vitamin E derivative as a cure for TNBS-induced colitis in rats.
Effect of Eucommia ulmoides Leaf Extract on Chronic Dextran Sodium Sulfate-Induced Colitis in Mice.
Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats.
Effect of intracolonic benzalkonium chloride on trinitrobenzene sulphonic acid-induced colitis in the rat.
Effect of N-acetylcysteine on colitis induced by acetic acid in rats.
Effect of putative phospholipase A2 inhibitors on acetic acid-induced acute colitis in the rat.
Effect of Quercetin Monoglycosides on Oxidative Stress and Gut Microbiota Diversity in Mice with Dextran Sodium Sulphate-Induced Colitis.
Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat.
Effects of antioxidant therapy on leukocyte myeloperoxidase and cu/zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis.
Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat.
Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: the roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Effects of cyclosporine or FK506 in chronic colitis.
Effects of Exopolysaccharide-Producing Probiotic Strains on Experimental Colitis in Rats.
Effects of FK506 on an experimental model of colitis in rats.
Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats.
Effects of recombinant human intestinal trefoil factor on trinitrobenzene sulphonic acid induced colitis in rats.
Effects of the neutrophil elastase inhibitor (ONO-6818) on acetic acid induced colitis in Syrian hamsters.
Effects of trimetazidine on acetic acid-induced colitis in female Swiss rats.
Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis.
Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis.
Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis.
Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis.
Electroacupuncture ameliorates experimental colitis induced by acetic acid in rat.
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis.
Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology.
Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats.
Environmental enrichment and gut inflammation modify stress-induced c-Fos expression in the mouse corticolimbic system.
Epiisopiloturine, an imidazole alkaloid, reverses inflammation and lipid peroxidation parameters in the Crohn disease model induced by trinitrobenzenosulfonic acid in Wistar rats.
Epithelial heparin delivery via microspheres mitigates experimental colitis in mice.
Essential Role of Growth Hormone and IGF-1 in Therapeutic Effect of Ghrelin in the Course of Acetic Acid-Induced Colitis.
Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model.
Evaluation of anti-colitic effect of fluvoxamine against acetic acid-induced colitis in normal and reserpinized depressed rats.
Evaluation of in vivo efficacy and toxicity of prednisolone-loaded hydrogel-based drug delivery device.
Evaluation of the role of neutrophils in the pathogenesis of acetic acid-induced colitis in mice.
Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis.
Exacerbation of Oxazolone Colitis by Infection with the Helminth Hymenolepis diminuta. Involvement of IL-5 and Eosinophils.
Exogenous Ghrelin Accelerates the Healing of Acetic Acid-Induced Colitis in Rats.
Experimental colitis in rats with portal hypertension and liver disease.
Expression of alternatively spliced variants of Na-Ca-exchanger-1 in experimental colitis: role in reduced colonic contractility.
Expression of ICAM-1 and acute inflammatory cell infiltration in the early phase of radiation colitis in rats.
Expression of Na-H exchanger-8 isoform is suppressed in experimental colitis in adult rat: lack of reversibility by dexamethasone.
Extracellular DNA as a Prognostic and Therapeutic Target in Mouse Colitis under DNase I Treatment.
Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.
Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.
Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats.
Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis.
Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-?B activation.
Ginsenoside Rd ameliorates colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation in mice.
Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo.
Glycoprotein isolated from Ulmus davidiana Nakai modulates inflammatory related factors in mouse colonic tissues.
Goniothalamin prevents the development of chemically induced and spontaneous colitis in rodents and induces apoptosis in the HT-29 human colon tumor cell line.
Granisetron ameliorates acetic acid-induced colitis in rats.
Granulocyte infiltration in experimental colitis in the rat is interleukin-1 dependent and leukotriene independent.
Halofuginone reduces the inflammatory responses of DSS-induced colitis through metabolic reprogramming.
Halofuginone, a Specific Inhibitor of Collagen Type 1 Synthesis, Ameliorates Oxidant Colonic Damage in Rats with Experimental Colitis.
Healing effects of Aegle marmelos (L.) Correa fruit extract on experimental colitis.
Heligmosmoides polygyrus fourth stages induce protection against DSS- induced colitis and change opioid expression in the intestine.
Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis.
Heme oxygenase-1 prevents murine intestinal inflammation.
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.
Hydroalcoholic extract of Brazilian red propolis exerts protective effects on acetic acid-induced ulcerative colitis in a rodent model.
Hydroxyproline Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice: Involvment of the NF-?B Signaling and Oxidative Stress.
Hyperbaric oxygen improves healing in experimental rat colitis.
Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis.
Hyperthermia ameliorates 2,4,6-trinitrobenzene sulphonic acid-induced colitis in rats: the role of heat shock proteins.
Imaging biomarkers of inflammation in situ with functionalized quantum dots in the dextran sodium sulfate (DSS) model of mouse colitis.
Impact of disrupting adenosine A(3) receptors (A(3) (-/-)AR) on colonic motility or progression of colitis in the mouse.
Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide.
Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.
Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis.
In vitro and in vivo inhibitory activity of 6-amino-2,4,5-trimethylpyridin-3-ols against inflammatory bowel disease.
In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice.
Indomethacin worsens and a leukotriene biosynthesis inhibitor accelerates mucosal healing in rat colitis.
Induction of colitis in mice with food allergen-specific immune response.
Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis.
Inflammatory bowel disease in rats: bacterial and chemical interaction.
Inflammatory mediators in cotton-top tamarins (CTT) with acute and chronic colitis.
Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.
Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.
Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.
Inhibitory effect of ?-sitosterol on TNBS-induced colitis in mice.
Insulin-like growth factor-3 knockout mice are resistant to experimental dextran sulfate sodium colitis.
Interleukin 10 gene transfer prevents experimental colitis in rats.
Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice.
Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis.
Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.
Intestinal mononuclear cells primed by systemic interleukin-12 display long-term ability to aggravate colitis in mice.
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.
Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia.
Isoliquiritigenin ameliorates dextran sulfate sodium-induced colitis through the inhibition of MAPK pathway.
Knockout of Ste20-Like Proline/Alanine-Rich Kinase (SPAK) Attenuates Intestinal Inflammation in Mice.
Lack of TNFRI signaling enhances annexin A1 biological activity in intestinal inflammation.
Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c Mice.
Lactobacillus plantarum CQPC06 Activity Prevents Dextran Sulfate Sodium-Induced Colitis by Regulating the IL-8 Pathway.
Lactobacillus sakei K17, an inducer of IL-10 expression in antigen-presenting cells, attenuates TNBS-induced colitis in mice.
Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance.
Mangiferin attenuates DSS colitis in mice: Molecular docking and in vivo approach.
Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis.
Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.
Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.
MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis.
Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats.
Mentha longifolia protects against acetic-acid induced colitis in rats.
Methotrexate is effective in reactivated colitis and reduces inflammatory alterations in mesenteric adipose tissue during intestinal inflammation.
Modulating effect of Biophytum sensitivum extract on rats with acetic acid-induced ulcerative colitis.
Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat.
Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis.
Modulatory effects of estrogen in two murine models of experimental colitis.
Molecular basis of altered contractility in experimental colitis: expression of L-type calcium channel.
Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-?B inactivation.
Mucosal protective activity of prostaglandin analogs in rodent colonic inflammation.
Myeloperoxidase activity of the large intestine in an equine model of acute colitis.
N-Methyl-d-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat.
N-methyl-d-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats.
Nanoparticle-based clodronate delivery mitigates murine experimental colitis.
Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.
Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats.
Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P.
Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice.
Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis.
NEUTROPHIL ELASTASE INHIBITOR SUPPRESSES IL-17 BASED INFLAMMATION OF MURINE EXPERIMENTAL COLITIS.
Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat.
Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice.
Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation.
Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Novel effects of ectoine, a bacteria-derived natural tetrahydropyrimidine, in experimental colitis.
Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors.
NOX1/NADPH Oxidase Expressed in Colonic Macrophages Contributes to the Pathogenesis of Colonic Inflammation in Trinitrobenzene Sulfonic Acid-Induced Murine Colitis.
O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
Obestatin Accelerates the Healing of Acetic Acid-Induced Colitis in Rats.
Oenothera rosea L´Hér. ex Ait attenuates acute colonic inflammation in TNBS-induced colitis model in rats: in vivo and in silico myeloperoxidase role.
On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators.
On the specificity of altered muscle function in experimental colitis in rats.
Opposite role of tumor necrosis factor receptors in dextran sulfate sodium-induced colitis in mice.
Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance.
Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.
Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-? siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis.
Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.
Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats.
Participation of mast cells in colitis inflammation induced by dextran sulfate sodium.
PepT1 expressed in immune cells has an important role in promoting the immune response during experimentally induced colitis.
Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats.
Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway.
Polydatin Ameliorates DSS-Induced Colitis in Mice through Inhibition of Nuclear Factor-kappaB Activation.
Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance.
Porcine ?-Defensin 2 Attenuates Inflammation and Mucosal Lesions in Dextran Sodium Sulfate-Induced Colitis.
PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism.
Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis.
Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber.
Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.
Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence.
Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators.
Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in mice.
Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.
Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis.
Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.
Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress.
Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines.
Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats.
Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
Protective effect of 4-methoxy-5-hydroxycanthin-6-one, a natural alkaloid, on dextran sulfate sodium-induced rat colitis.
Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-?B signaling pathways.
Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice.
Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators.
Protective Effect of Comaruman, a Pectin of Cinquefoil Comarum palustre L., on Acetic Acid-Induced Colitis in Mice.
Protective effect of Copaifera langsdorffii oleo-resin against acetic acid-induced colitis in rats.
Protective effect of epidermal growth factor in an experimental model of colitis in rats.
Protective effect of isoquercitrin against acute dextran sulfate sodium-induced rat colitis depends on the severity of tissue damage.
Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits.
Protective effect of Periplaneta americana extract in ulcerative colitis rats induced by dinitrochlorobenzene and acetic acid.
Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats.
Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats.
Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response.
Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.
RAMP1 suppresses mucosal injury from dextran sodium sulfate-induced colitis in mice.
Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs.
Repeated predictable stress causes resilience against colitis-induced behavioral changes in mice.
Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP.
Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis.
Role of endothelins in trinitrobenzene sulfonic acid-induced colitis in rats.
Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus.
Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis.
Role of osteopontin in neutrophil function.
Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: increased mortality after gammadelta T cell depletion and no effect of alphabeta T cell depletion.
Role of TRPV1 and TRPA1 in visceral hypersensitivity to colorectal distension during experimental colitis in rats.
Salicylate hydroxylation as an indicator of hydroxyl radical generation in dextran sulfate-induced colitis.
Salvia miltiorrhiza increases the expression of transcription factor Foxp3 in experimental murine colitis.
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis.
Serine Alleviates Dextran Sulfate Sodium-Induced Colitis and Regulates the Gut Microbiota in Mice.
Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.
Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis.
Soybean and fish oil mixture increases IL-10, protects against DNA damage and decreases colonic inflammation in rats with dextran sulfate sodium (DSS) colitis.
Spatial and temporal expression of tachykinins and NK1- and NK2-receptor gene during TNB induced colitis in rats.
St. John's wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and/or P-glycoproteins.
Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved.
Studies on purine enzymes in experimental colitis.
Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice.
Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
Suppression of experimental colitis in mice by CD11c+ dendritic cells.
Suppression of NF-?B signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone.
Suppression of TNBS-induced colitis in rats by 4-methylesculetin, a natural coumarin: comparison with prednisolone and sulphasalazine.
Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis.
Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF.
T Cell-Specific Knockout of STAT3 Ameliorates Dextran Sulfate Sodium-Induced Colitis by Reducing the Inflammatory Response.
Tangeretin Inhibits IL-12 Expression and NF-?B Activation in Dendritic Cells and Attenuates Colitis in Mice.
Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis.
Targeting sphingosine kinase 1 (SphK1) and apoptosis by colon-specific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats.
Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.
The ameliorative effect of a Lactobacillus strain with good adhesion ability against dextran sulfate sodium-induced murine colitis.
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.
The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats.
The correlation between NF-?B inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats.
The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat.
The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat.
The effect of memantine on trinitrobenzene sulfonic acid-induced ulcerative colitis in mice.
The effects of caffeic acid phenethyl ester (CAPE) on TNBS-induced colitis in ovariectomized rats.
The influence of pretreatment with ghrelin on the development of acetic-acid-induced colitis in rats.
The Mixture of Anemarrhena asphodeloides and Coptis chinensis Attenuates High-Fat Diet-Induced Colitis in Mice.
The natural compound celastrol inhibits necroptosis and alleviates ulcerative colitis in mice.
The protective action of radix Astragalus membranaceus against hapten-induced colitis through modulation of cytokines.
The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation.
The relevance of kinin B1 receptor upregulation in a mouse model of colitis.
The Rhizome Mixture of Anemarrhena asphodeloides and Coptis chinensis Attenuates Mesalazine-Resistant Colitis in Mice.
The role of transient mucosal ischemia in acetic acid-induced colitis in the rat.
The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.
The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
Therapeutic potential of follistatin for colonic inflammation in mice.
Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives.
Thiadiazolidinone-8 Ameliorates Inflammation Associated with Experimental Colitis in Mice.
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice.
Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
Transmucosal potential difference in experimental colitis in rats.
Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice.
Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats.
Treatment with Met-RANTES decreases bacterial translocation in experimental colitis.
TRPM8 activation attenuates inflammatory responses in mouse models of colitis.
Upregulation of P-glycoprotein by Probiotics in Intestinal Epithelial Cells and in the Dextran Sulfate Sodium Model of Colitis in Mice.
UROCORTIN 1 MODULATES IMMUNOSIGNALING IN A RAT MODEL OF COLITIS VIA CORTICOTROPIN-RELEASING FACTOR RECEPTOR 2.
Uterine motor alterations and estrous cycle disturbances associated with colonic inflammation in the rat.
Vagus nerve integrity and experimental colitis.
Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis.
Variable response to probiotics in two models of experimental colitis in rats.
VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice.
Verapamil alters eicosanoid synthesis and accelerates healing during experimental colitis in rats.
VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Worm proteins of Schistosoma mansoni reduce the severity of experimental chronic colitis in mice by suppressing colonic proinflammatory immune responses.
Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair.
Zinc sulphate solution enema decreases inflammation in experimental colitis in rats.
[Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease].
[Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease]
[Study on the colon specific delivery of prednisolone using chitosan capsules]
[The effect of interleukin-1 beta interleukin-8 in the pathogenesis of experimental colitis and evaluation of interleukin-1 receptor antagonist therapy]
Colitis, Collagenous
Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease and Collagenous Colitis: No Association with Lactoferrin, ?-Glucuronidase, Myeloperoxidase, or Proteinase 3.
Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis.
Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients.
Colitis, Microscopic
Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats.
Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats.
Ozone enema: a model of microscopic colitis in rats.
Colitis, Ulcerative
A new natural angelica polysaccharide based colon-specific drug delivery system.
Activation of NF-?B: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis.
Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis.
Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis.
Effect of N-acetylcysteine on colitis induced by acetic acid in rats.
Effects of antioxidant therapy on leukocyte myeloperoxidase and cu/zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis.
Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
Evaluation of Fecal Myeloperoxidase as a Biomarker of Disease Activity and Severity in Ulcerative Colitis.
Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA.
Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.
Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis.
Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis.
Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease.
Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: Association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.
Oral Bifidobacterium longum expressing alpha-melanocyte-stimulating hormone to fight experimental colitis.
p-ANCA target antigens in ulcerative colitis.
Studies on the expression and function of beta-3-adrenoceptors in the colon of rats with acetic acid-induced colitis.
The Attenuation of Scutellariae radix Extract on Oxidative Stress for Colon Injury in Lipopolysaccharide-induced RAW264.7 Cell and 2,4,6-trinitrobenzene Sulfonic Acid-induced Ulcerative Colitis Rats.
Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
[Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis]
[Therapeutic effect of anti-CXCL1 neutralizing antibody on ?acute ulcerative colitis in mice].
Colonic Diseases
Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse.
Colonic Neoplasms
Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
Colorectal Neoplasms
Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.
Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis.
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer.
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
Increased lipid peroxidation in malignant tissues of patients with colorectal cancer.
Patients With Colorectal Cancer Are Characterized by Increased Concentration of Fecal Hb-Hp Complex, Myeloperoxidase, and Secretory IgA.
Common Cold
Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds.
Common Variable Immunodeficiency
Chitotriosidase enzyme activity: is this a possible chronic inflammation marker in children with common variable immunodeficiency and early atherosclerosis?
Fungal infections in primary immunodeficiencies.
Invasive fungal infections in congenital immunodeficiencies.
Salivary defense factors and oral health in patients with common variable immunodeficiency.
Communicable Diseases
Association between the neutrophil myeloperoxidase index and subsets of bacterial infections.
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
Compartment Syndromes
N-acetylcysteine Protects Striated Muscle in a Model of Compartment Syndrome.
Conjunctivitis
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
Conjunctivitis, Allergic
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
Conjunctivitis, Bacterial
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
Connective Tissue Diseases
Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis.
Corneal Opacity
Pseudomonas aeruginosa-induced inflammation in the rat extended-wear contact lens model.
Coronary Artery Disease
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians.
A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity.
Active and total myeloperoxidase in coronary artery disease and relation to clinical instability.
Association between adipokine and myeloperoxidase levels in patients with coronary artery disease.
Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
Association between myeloperoxidase levels and risk of coronary artery disease.
Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia.
Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes.
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.
Dysfunctional HDL and atherosclerotic cardiovascular disease.
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease.
Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.
Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease.
Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease.
Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
Matrix Metalloproteinase-9 (MMP-9) and Myeloperoxidase (MPO) Levels in Patients with Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography.
Meta-analysis of myeloperoxidase gene polymorphism and coronary artery disease susceptibility.
Myeloperoxidase Activity and Oxidized Amino Acids as Biomarkers in Chronic Kidney Disease and Coronary Artery Disease.
Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.
Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease.
Myeloperoxidase is not useful for detecting stress inducible myocardial ischemia but may be indicative of the severity of coronary artery disease.
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.
Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.
Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis.
Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease.
Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export.
Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
Plasma myeloperoxidase is related to the severity of coronary artery disease.
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects.
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
Role of FLAP and PDE4D in Myocardial Infarction and Stroke: Target Discovery and Future Treatment Options.
Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease.
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.
The role of myeloperoxidase in the pathogenesis of coronary artery disease.
The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
Trans-vessel gradient of myeloperoxidase in coronary artery disease.
Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males.
Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
[Correlation between MPO 129 A/G polymorphism and severity of coronary artery disease].
Coronary Disease
Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.
Biomarkers in acute myocardial infarction.
Does mercury promote lipid peroxidation? An in vitro study concerning mercury, copper, and iron in peroxidation of low-density lipoprotein.
Elevated Serum Myeloperoxidase Activities are Significantly Associated with the Prevalence of ACS and High LDL-C Levels in CHD Patients.
Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
Exercise-based rehabilitation improves cardiorespiratory fitness but does not modulate myeloperoxidase levels in coronary heart disease patients.
Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress.
Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.
Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study.
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
Plasma myeloperoxidase concentration predicts the presence and severity of coronary disease in patients with chest pain and negative troponin-T.
Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
Supplementary taurine may stabilize atheromatous plaque by antagonizing the activation of metalloproteinases by hypochlorous acid.
The Diagnostic and Prognostic Performance of Myeloperoxidase Plasma Levels as Compared to Sensitive Troponins in Patients Admitted with Acute Onset Chest Pain.
The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans.
Therapeutic dosages of raloxifene do not modify myeloperoxidase and F2alpha-isoprostane levels in postmenopausal women.
[Change of serum myeloperoxidase and lipoxin A4 level in coronary heart disease patients with anxiety and/or depression].
Coronary Stenosis
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
Cough
Cough, airway inflammation, and mild asthma exacerbation.
Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough.
Increased PMA-induced chemiluminescence from whole blood of patients with bronchial hyperreactivity.
Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke.
Relationship between cough, cough receptor sensitivity and asthma in children.
Cranial Nerve Diseases
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated hypertrophic pachymeningitis presenting with multiple cranial nerve palsies and diabetes insipidus.
Craniocerebral Trauma
Plasma myeloperoxidase and vitamin E levels in head injury: preliminary results related to outcome.
Crohn Disease
Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease.
Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease.
Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway.
Cryoglobulinemia
An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract.
Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature.
Cryptogenic Organizing Pneumonia
Cavitating BOOP associated with myeloperoxidase deficiency in a floor cleaner with an incidental heavy exposure to benzalkonium compounds.
Cystic Fibrosis
An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis.
Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis.
Ceramide is Increased in the Lower Airway Epithelium of People with Advanced Cystic Fibrosis Lung Disease.
Clinical proteomics in chronic inflammatory diseases: A review.
Demonstration of human leukocyte degranulation induced by sera from homozygotes and heterozygotes for cystic fibrosis.
Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.
Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis.
Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury.
Hypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseases.
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis.
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1).
Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection.
Myeloperoxidase and protein oxidation in cystic fibrosis.
Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis.
Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.
Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.
Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: green is not good.
Oxidation contributes to low glutathione in the airways of children with cystic fibrosis.
Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency.
Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum.
Reactive sulfur species: kinetics and mechanism of the reaction of hypothiocyanous acid with cyanide to give dicyanosulfide in aqueous solution.
Relationship between disease severity and inflammatory markers in cystic fibrosis.
Serum myeloperoxidase in cystic fibrosis patients receiving systemic antibiotics.
Cystitis
Effects of the compounds MV8608 and MV8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats.
Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats.
Cystitis, Interstitial
Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model.
Cysts
The interaction of Acanthamoeba castellanii cysts with macrophages and neutrophils.
Deafness
The Sequential Development of Antiglomerular Basement Membrane Nephritis and Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Death, Sudden, Cardiac
Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling.
Dehydration
Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells.
Delirium
Associations of markers of inflammation and coagulation with delirium during critical illness.
Dementia
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study.
Demyelinating Diseases
Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.
Dental Caries
Antimicrobial systems of human whole saliva in relation to dental caries, cariogenic bacteria, and gingival inflammation in young adults.
Dermatitis
Myeloperoxidase deficiency manifesting as pustular candidal dermatitis.
Topical film prepared with Rhus verniciflua extract-loaded pullulan hydrogel for atopic dermatitis treatment.
Dermatitis Herpetiformis
Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
Dermatitis, Atopic
Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis.
IL-6, VEGF, KC and RANTES Are a Major Cause of a High Irritant Dermatitis to Phthalic Anhydride in C57BL/6 Inbred Mice.
Myeloperoxidase of polymorphonuclear leukocytes in psoriasis vulgaris.
Systemic vasculitis in a patient with atopic dermatitis, eosinophilia, pulmonary-renal syndrome, and positive myeloperoxidase antibody: a classification conundrum.
Dermatitis, Contact
Caffeic acid reduces cutaneous tumor necrosis factor alpha (TNF-?), IL-6 and IL-1? levels and ameliorates skin edema in acute and chronic model of cutaneous inflammation in mice.
Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities.
Further studies on a mixture of fatty acids from sugar cane (Saccharum officinarum) wax oil in animal models of hypersensitivity.
Gut colonization by Candida albicans aggravates inflammation in the gut and extra-gut tissues in mice.
Dermatitis, Phototoxic
Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.
Diabetes Complications
Network Analysis of MPO and Other Relevant Proteins Involved in Diabetic Foot Ulcer and Other Diabetic Complications.
Diabetes Insipidus
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated hypertrophic pachymeningitis presenting with multiple cranial nerve palsies and diabetes insipidus.
Diabetes Mellitus
Carbamylation of LDL and its relationship with myeloperoxidase in Type 2 diabetes mellitus.
Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus.
Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus.
Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase.
Effects of diabetes on cytokines and oxidative organ injury in a rat model of sepsis.
Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase.
Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.
Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress.
Galega officinalis extract regulate the diabetes mellitus related violations of proliferation, functions and apoptosis of leukocytes.
High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess.
Levels of Nitric Oxide Metabolites and Myeloperoxidase in Subjects with Type 2 Diabetes Mellitus on Metformin Therapy?.
Myeloperoxidase deficiency manifesting as pustular candidal dermatitis.
Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus.
Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus.
The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: a case-control pilot study.
[Determination of neutrophil function by measuring superoxide production with whole blood flow cytometry]
[Increased myelopepoxidase activity is a risk factor for ishemic heart disease in patients with diabetes mellitus].
[Intervention effect of ganoderma lucidum spores on the changes of XOD, MPO and SDH in the testis tissue of NIDDM rats]
[Myeloperoxidase activity and glycogen levels in peripheral blood neutrophils in patients with well controlled diabetes mellitus type 1 and 2]
[Neutrophils as a source of factors that increase the length of the inflammatory phase of wound healing in patients with type 2 diabetes mellitus].
Diabetes Mellitus, Type 1
Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes.
Association between markers of endothelial dysfunction and early signs of renal dysfunction in pediatric obesity and type 1 diabetes.
Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase.
Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes.
Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus.
Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus.
Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients.
Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.
Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress.
High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
Hyperglycemia and Oxidative Stress Strengthen the Association Between Myeloperoxidase and Blood Pressure.
Insulitis in human diabetes: a histological evaluation of donor pancreases.
Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?
Levels of Nitric Oxide Metabolites and Myeloperoxidase in Subjects with Type 2 Diabetes Mellitus on Metformin Therapy?.
Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus.
Plasma markers of endothelial dysfunction in type 2 diabetics.
Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes.
The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: a case-control pilot study.
[Increased myelopepoxidase activity is a risk factor for ishemic heart disease in patients with diabetes mellitus].
[Neutrophils as a source of factors that increase the length of the inflammatory phase of wound healing in patients with type 2 diabetes mellitus].
Diabetes, Gestational
A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation.
Diabetic Ketoacidosis
Elevated Leukocyte Azurophilic Enzymes in Human Diabetic Ketoacidosis Plasma Degrade Cerebrovascular Endothelial Junctional Proteins.
Diabetic Nephropathies
Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.
Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
Diabetic Retinopathy
Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy.
DiGeorge Syndrome
Fungal infections in primary immunodeficiencies.
Invasive fungal infections in congenital immunodeficiencies.
Diphtheria
[Lymphocyte and neutrophil cytochemistry in the dynamics of different forms of diphtheria in adults]
Down Syndrome
Congenital disorders of the function of polymorphonuclear neutrophils.
Trisomy 21 as the sole acquired karyotypic abnormality in an adult patient with CD7-positive acute myeloid leukemia.
[Oxidative metabolism in polymorphonuclear granulocytes of children with trisomy 21]
Drug Eruptions
Bullous allergic drug eruption with presence of myeloperoxidase and reorganization of the dermal vessels observed by using CD34 and collagen IV antibodies.
Drug Hypersensitivity
Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils.
Ductus Arteriosus, Patent
Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome.
Duodenal Ulcer
Association of the myeloperoxidase -468G-->A polymorphism with gastric inflammation and duodenal ulcer risk.
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Duodenitis
Effects of milk, prostaglandin, and antacid on experimentally induced duodenitis in the rat. Use of myeloperoxidase as an index of inflammation.
Dysentery
The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings.
Dysentery, Bacillary
Innate immune responses in children and adults with Shigellosis.
Dyslipidemias
A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia.
Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?
Dyspnea
An unusual presentation of antineutrophil cytoplasmic antibody-associated vasculitis: discrepancy between histopathology and clinical presentation.
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD.
Eclampsia
Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia.
Ectodermal Dysplasia 1, Anhidrotic
Glucocorticoid pretreatment suppresses chemokine expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention.
Eczema
Serum inflammatory markers and effects of age and tobacco smoke exposure in young non-asthmatic children.
Embolism, Fat
From neurogenic pulmonary edema to fat embolism syndrome: a brief review of experimental and clinical investigations of acute lung injury and acute respiratory distress syndrome.
Encephalitis
FeTPPS Reduces Secondary Damage and Improves Neurobehavioral Functions after Traumatic Brain Injury.
Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model.
Encephalomyelitis
Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.
Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.
Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.
Endocarditis, Bacterial
Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis.
Endometrial Neoplasms
Relation of MPO, MnSOD, NQO1 gene variants in endometrial carcinoma in the line of PCR-RFLP methods.
Endometriosis
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Evaluation of Total, Active, and Specific Myeloperoxidase Levels in Women with and without Endometriosis.
Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis.
Identification of local angiogenic and inflammatory markers in the menstrual blood of women with endometriosis.
Inflammatory markers in endometriosis: reduced peritoneal neutrophil response in minimal endometriosis.
Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis†.
Myeloperoxidase as a Potential Target in Women With Endometriosis Undergoing IVF.
Endometritis
Alpinetin ameliorates inflammatory response in LPS-induced endometritis in mice.
Associations of periparturient plasma biochemical parameters, endometrial leukocyte esterase and myeloperoxidase, and bacterial detection with clinical and subclinical endometritis in postpartum dairy cows.
High concentrations of myeloperoxidase in the equine uterus as an indicator of endometritis.
Oridonin Ameliorates Lipopolysaccharide-Induced Endometritis in Mice via Inhibition of the TLR-4/NF-?Bpathway.
Endotoxemia
Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock.
Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation.
ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice.
Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice.
Inhibition of 3-Hydroxy-3-Methyl-Glutaryl-Coenzyme A Reductase Reduces Leukocyte Recruitment and Hepatocyte Apoptosis in Endotoxin-Induced Liver Injury.
Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia.
Intragastric administration with recombinant Lactococcus lactis producing heme oxygenase-1 prevents lipopolysaccharide-induced endotoxemia in rats.
Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide.
Role of MCP-1 in endotoxemia and sepsis.
Role of neutrophils in arginine-asymmetric dimethylarginine pathway subsequent to endotoxemia.
Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia.
Time-related changes in equine neutrophils after experimental endotoxemia: myeloperoxidase staining, size, and numbers.
Enteritis
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.
Enterocolitis
Inflammatory Bowel Disease.
Pectin-supplemented enteral diet reduces the severity of methotrexate induced enterocolitis in rats.
Study of intestinal anti-inflammatory activity of Phoenix loureiroi Kunth (Arecaceae) fruit.
Eosinophilia
3q26 chromosomal anomalies in acute myeloid leukemia: First descriptions from India.
ANCA-Associated Vasculitis - Revisited, and its Association with Autoimmune Thyroid Disease.
Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association.
Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.
Chronic pulmonary aspergillosis may cause eosinophilic granulomatosis with polyangiitis via allergic bronchopulmonary aspergillosis.
Churg-Strauss syndrome in a patient previously diagnosed with multiple sclerosis.
Churg-strauss syndrome presenting with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis.
Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist.
Differential Diagnosis of Churg-Strauss Syndrome with Tingling Sensation and Weakness of the Lower Extremities.
Eosinophil peroxidase differs from neutrophil myeloperoxidase in its ability to bind antineutrophil cytoplasmic antibodies reactive with myeloperoxidase.
Hypoxia-inducible factor-1? inhibition modulates airway hyperresponsiveness and nitric oxide levels in a BALB/c mouse model of asthma.
MPO-ANCA-positive crescentic necrotizing glomerulonephritis and tubulointerstitial nephritis with renal eosinophilic infiltration and peripheral blood eosinophilia.
Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.
Smoking and atopy as determinants of sputum eosinophilia and bronchial hyper-responsiveness in adults with normal lung function.
Systemic vasculitis in a patient with atopic dermatitis, eosinophilia, pulmonary-renal syndrome, and positive myeloperoxidase antibody: a classification conundrum.
Eosinophilia-Myalgia Syndrome
Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
Epididymitis
Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis.
Epidural Neoplasms
Case Report: Myelodysplastic syndrome- associated myeloid sarcoma: an unusual clinical presentation of a rare disease.
Epilepsy
Myeloperoxidase: Bridging the gap in neurodegeneration.
Erectile Dysfunction
Plasma myeloperoxidase in patients with erectile dysfunction of arteriogenic- and non-arteriogenic origin: association with markers of endothelial dysfunction.
Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study.
Erythema
Multiple topical applications of arachidonic acid to mouse ears induce inflammatory and proliferative changes.
Erythema Nodosum
Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide.
Escherichia coli Infections
Suppression of the granulocyte colony-stimulating factor response to Escherichia coli challenge by alcohol intoxication.
Esophageal Neoplasms
Factors related to impaired bactericidal activity in patients with esophageal cancer.
Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II).
Impaired neutrophil bactericidal activity correlates with the infection occurring after surgery for esophageal cancer.
Esophagitis
Regulation of Na/H exchanger-1 in gastroesophageal reflux disease: possible interaction of histamine receptor.
Esophagitis, Peptic
Protective Effect of ECQ on Rat Reflux Esophagitis Model.
Essential Hypertension
Association of myeloperoxidase gene variation with carotid atherosclerosis in patients with essential hypertension.
Gender-specific protective effect of the -463G>A polymorphism of myeloperoxidase gene against the risk of essential hypertension in Russians.
Exanthema
Histologic findings in skin biopsy of a JMML rash: a case report and review of literature.
Eye Manifestations
Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review.
Fabry Disease
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease.
Facial Paralysis
Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
Familial Primary Pulmonary Hypertension
Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension.
Fatty Liver
An experimental research on chronic intermittent hypoxia leading to liver injury.
Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.
Fetal Growth Retardation
Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Pathological uterine perfusion in the second trimester is not associated with neutrophil activation.
Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.
Foot Ulcer
Network Analysis of MPO and Other Relevant Proteins Involved in Diabetic Foot Ulcer and Other Diabetic Complications.
Gallstones
Inflammation and a thickened mucus layer in mice with cholesterol gallstones.
Inflammatory properties of bile from dogs with pigment gallstones.
Gastritis
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
Association of the myeloperoxidase -463G-->A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis.
Association of the myeloperoxidase -468G-->A polymorphism with gastric inflammation and duodenal ulcer risk.
Deletion of the acid-sensing ion channel ASIC3 prevents gastritis-induced acid hyperresponsiveness of the stomach-brainstem axis.
Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
Environmental enrichment and gut inflammation modify stress-induced c-Fos expression in the mouse corticolimbic system.
Experimental gastritis in mice enhances anxiety in a gender-related manner.
Increase in gastric acid-induced afferent input to the brainstem in mice with gastritis.
p53 expression in the gastric mucosa before and after eradication of Helicobacter pylori.
The effect of synthetic ceramide analogues on gastritis and esophagitis in rats.
The polysaccharide-rich tea of Ximenia americana barks prevents indomethacin-induced gastrointestinal damage via neutrophil inhibition.
Gastritis, Atrophic
Association of the myeloperoxidase -463G-->A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis.
Gastroesophageal Reflux
Gastroesophageal reflux patients' defective antioxidative capacity in the proximal esophageal mucosa before antireflux surgery and also after 4-year follow-up.
Regulation of Na/H exchanger-1 in gastroesophageal reflux disease: possible interaction of histamine receptor.
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
Gastrointestinal Diseases
Association of Myeloperoxidase -463 G/A Polymorphism with Clinical Outcome of Helicobacter Pylori infection in Iranian Patients with Gastrointestinal Diseases.
Low serum myeloperoxidase in autistic children with gastrointestinal disease.
Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease.
Gastrointestinal Hemorrhage
An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract.
Giant Cell Arteritis
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
Gingival Diseases
S100, bcl2 and myeloperoxid protein expirations during periodontal inflammation.
Gingival Overgrowth
Salivary myeloperoxidase of young adult humans.
Gingivitis
Characterization and comparison of neutrophil extracellular traps in gingival samples of periodontitis and gingivitis: A pilot study.
Crevicular fluid myeloperoxidase at healthy, gingivitis and periodontitis sites.
Effects of nonopsonized Escherichia coli on myeloperoxidase activity in medium used for incubation of leukocytes from patients with gingivitis and periodontitis.
Gingival Inflammation and Salivary or Serum Granulocyte Secreted Enzymes in Patients With Polycystic Ovary Syndrome.
Longitudinal study of salivary proteinases during pregnancy and postpartum.
Salivary levels of MPO, MMP-8 and TIMP-1 are associated with gingival inflammation response patterns during experimental gingivitis.
[Crevicular fluid myeloperoxidase and periodontitis disease]
Glaucoma
Distribution of oxidation enzyme eNOS and myeloperoxidase in primary open angle glaucoma.
Glaucoma, Open-Angle
Distribution of oxidation enzyme eNOS and myeloperoxidase in primary open angle glaucoma.
Glioblastoma
Expressions of some vital molecules: glioblastoma multiforme versus normal tissues.
Glioma
Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging.
Glomerulonephritis
A case of ANCA-associated vasculitis with glomerular eosinophilic infiltration: a possible pathogenic implication.
A case of membranous nephropathy and myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
A case of microscopic polyangiitis presenting with acute spinal subdural hemorrhage.
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody(MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy.
A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
A concomitant case of giant cell arteritis and microscopic polyangiitis with hemoperitoneum by rupture of the gastroepiploic artery.
A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.
A Novel Mouse Model for MPO-ANCA-Associated Glomerulonephritis.
A rare case of concurrent myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated necrotising and crescentic glomerulonephritis and membranous glomerulonephritis.
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies.
An adolescent case of anti-neutrophil cytoplasmic autoantibodies-associated crescentic glomerulonephritis complicated with subclinical autoimmune thyroiditis.
Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis.
ANCA-Associated Vasculitis - Revisited, and its Association with Autoimmune Thyroid Disease.
Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis.
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.
Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment.
Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis.
Antimyeloperoxidase antibodies in patients with extracapillary glomerulonephritis.
Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.
Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.
Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
AP-VAS 2012 case report: a case of myeloperoxidase antineutrophil cytoplasmic antibody-positive microscopic polyangiitis with rapidly progressive glomerulonephritis and hearing loss.
Are animal models of vasculitis suitable tools?
Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis.
Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.
Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: A case report.
Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.
Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Development of intracerebral hemorrhage in the short-term clinical course of a patient with microscopic polyangiitis without neurological symptoms at diagnosis: an autopsy case.
Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules.
Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis.
Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody.
Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis.
Dual anti-neutrophil cytoplasmic antibody-related pauci-immune crescentic glomerulonephritis in a patient with Sjögren's syndrome.
Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis.
Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis.
Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.
Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Genetic dissection of vasculitis, myeloperoxidase-specific antineutrophil cytoplasmic autoantibody production, and related traits in spontaneous crescentic glomerulonephritis-forming/kinjoh mice.
Glomerular crescents predominantly express cadherin-catenin complex in pauci-immune-type crescentic glomerulonephritis.
High prevalence of Chlamydophila pneumoniae infection in patients with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-associated glomerulonephritis.
Idiopathic lung fibrosis and anti myeloperoxidase glomerulonephritis: the tree that hides the forest.
Idiopathic rapidly progressive (crescentic) glomerulonephritis with myeloperoxidase antibodies--a new entity linked to female sex?
IgG Glycan Hydrolysis Attenuates ANCA-Mediated Glomerulonephritis.
Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase.
Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis.
Immunopathologic co-localization of MPO, IgG, and C3 in glomeruli in human MPO-ANCA-associated glomerulonephritis.
Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study.
In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
Increased serum levels of S100A12 in patients with MPO-ANCA-associated glomerulonephritis.
Interaction of myeloperoxidase and elastase enzyme activity with the antihypertensive agents hydralazine and dihydralazine.
Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers.
Mediastinal fibrosis and positive antineutrophil cytoplasmic antibodies: coincidence or common etiology?
Membranous glomerulonephritis associated with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Microscopic polyangiitis associated with thymoma, exacerbating after thymectomy.
Microscopic polyangiitis presented with biopsy-confirmed pleuritis.
MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature.
MPO-ANCA-positive crescentic necrotizing glomerulonephritis and tubulointerstitial nephritis with renal eosinophilic infiltration and peripheral blood eosinophilia.
Mycobacterium Kansasii Infection and Microscopic Polyangiitis: An Unexpected Association.
Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
Myeloperoxidase Anti-cytoplasmic Antibody Related Crescentic Glomerulonephritis in a Patient with IgG3? Monoclonal Immunoglobulin Deposition Disease with Membranous Features.
Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated Crescentic and Necrotizing Glomerulonephritis (GN) with Membranoproliferative GN Features.
Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis.
Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
Myeloperoxidase antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in a very elderly patient with generalized vasculitis at autopsy.
Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angiitis.
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease.
Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis.
Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Pediatric case of crescentic post-streptococcal glomerulonephritis with myeloperoxidase anti-neutrophil cytoplasmic antibody.
Plasmapheresis for removal of myeloperoxidase antineutrophil cytoplasmic antibodies: a case report.
Pleural vasculitides of microscopic polyangiitis with asbestos-related plaques.
Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.
Presence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase Anti-Neutrophilic Cytoplasmic Antibodies in a Case of Rapidly Progressive Glomerulonephritis.
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis.
Protective Role of Mast Cells in Primary Systemic Vasculitis: A Perspective.
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Recovery of Renal Function in a Dialysis-dependent Patient with Microscopic Polyangiitis and both Myeloperoxidase Anti-neutrophil Cytoplasmic Antibodies and Anti-glomerular Basement Membrane Antibodies.
Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.
Renal transplantation in patients with microscopic polyarteritis and antimyeloperoxidase antibodies: report of three cases.
Renal-limited vasculitis with elevated levels of multiple antibodies.
Restriction in V kappa gene use and antigen selection in anti-myeloperoxidase response in mice.
Scleroderma with crescentic glomerulonephritis: a case report.
Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
Serum Procalcitonin Levels in Patients With Myeloperoxidase-Antineutrophil Cytoplasmic Antibodies-Associated Glomerulonephritis.
Significance of myeloperoxidase in rapidly progressive glomerulonephritis.
Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.
Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis.
Successful renal transplantation in a child with ANCA-associated microscopic polyangiitis.
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.
The onset of Graves' disease during the clinical course of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis.
The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.
Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors.
Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis.
Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody.
Vasculitis following implantation of a ventriculoperitoneal shunt tube made of silicone.
What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.
[A case of MPO-ANCA related vasculitis with transient leukoencephalopathy and multiple cerebral hemorrhage]
[A case of MPO-ANCA-associated vasculitis with membranous nephropathy].
[A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents]
[A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA positive interstitial pneumonia].
[A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis]
[Anti-neutrophil cytoplasmic autoantibody (ANCA) in systemic vasculitic syndrome]
[Are antineutrophil cytoplasmic antibodies pathogenic?]
[Autoantibodies associated with vasculitis]
[Clinical and pathogenetic aspects of kidney damage associated with neutrophilic cytoplasm antibodies]
[Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) -associated glomerulonephritis with acute pancreatitis: a case report].
[Pulmonary involvement in patients with myeloperoxidase specific-antineutrophil cytoplasmic antibody]
[Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis]
[Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases]
[Studies on functions of neutrophils in MPO-ANCA related glomerulonephiritis and plasma effect on MPO release from neutrophils]
[Two autopsy cases of ANCA-associated glomerulonephritis manifested after contrast medium use]
Glomerulonephritis, IGA
IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA.
Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series.
[Anti-myeloperoxidase and anti-lactoferrin antibodies in patients with IgA nephropathy and Henoch-Schönlein purpura]
Glomerulonephritis, Membranous
A case of membranous nephropathy and myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody(MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy.
A rare case of concurrent myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated necrotising and crescentic glomerulonephritis and membranous glomerulonephritis.
Membranous glomerulonephritis associated with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
Significance of myeloperoxidase in rapidly progressive glomerulonephritis.
Glomerulosclerosis, Focal Segmental
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Congenital disorders of the function of polymorphonuclear neutrophils.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Glucosephosphate Dehydrogenase Deficiency
Congenital disorders of the function of polymorphonuclear neutrophils.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Glycogen Storage Disease Type II
Oral Health Status of Patients with Lysosomal Storage Diseases in Poland.
Gout
Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
P2Y6 Receptor Antagonist MRS2578 Inhibits Neutrophil Activation and Aggregated Neutrophil Extracellular Trap Formation Induced by Gout-Associated Monosodium Urate Crystals.
Graft vs Host Disease
Elevated Neutrophil Elastase in Tears of Ocular Graft-Versus-Host Disease Patients.
Granuloma
A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.
Anti-In?ammatory Potential of Hecogenin in Experimental Animals: Possible Involvement of Inflammatory Cytokines and Myeloperoxidase.
Differential effects of prednisolone and indomethacin on zymosan-induced inflammation in a modified murine tissue-chamber model.
Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules.
Essential oil of Myrtus communis inhibits inflammation in rats by reducing serum IL-6 and TNF-alpha.
Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis.
Evaluation of anti-inflammatory activity of the methanolic extract from Jungia rugosa leaves in rodents.
Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study.
Granulomatosis with Polyangiitis
A Case Report on Suspected Levamisole-Induced Pseudovasculitis.
A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Advances in pathogenesis and treatment of ANCA-associated vasculitis.
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
Autoantibodies in vasculitis.
Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association.
B cell epitope specificity in ANCA-associated vasculitis: does it matter?
Bilateral Facial Nerve Palsy due to Otitis Media Associated With Myeloperoxidase-Antineutrophil Cytoplasmic Antibody.
Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?
Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.
Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener's granulomatosis: a rare phenomenon.
Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.
Detection of anti-neutrophil cytoplasmic autoantibodies using the promyelocytic HL-60 cell-line.
Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules.
Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
Epitope-specific anti-neutrophil cytoplasmic antibodies: do they matter? Can they be detected?
Genetic variants in ANCA-associated vasculitis: a meta-analysis.
Granulomatosis with Polyangiitis Presenting as Pyrexia of Unknown Origin, Leukocytosis, and Microangiopathic Haemolytic Anemia.
IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis.
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.
Linked help from bacterial proteins drives autoantibody production in small vessel vasculitis.
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study.
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody-Positive Interstitial Pneumonia Associated with Granulomatosis with Polyangiitis Diagnosed by Surgical Lung Biopsy.
New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis).
Pathogenesis of ANCA-Associated Vasculitis: New Possibilities for Intervention.
Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.
Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma.
Positive c-ANCA in a Patient with Lymphoma and Without Vasculitis.
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.
Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
The phylogeny of proteinase 3/myeloblastin, the autoantigen in Wegener's granulomatosis, and myeloperoxidase as shown by immunohistochemical studies on human leukemic cell lines.
The significance of negative myeloperoxidase antineutrophil cytoplasmic antibodies and the role of cyclophosphamide in eosinophilic granulomatosis with polyangiitis.
The Successful Treatment of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-positive Hypertrophic Pachymeningitis in Patients with the Limited Form of Granulomatosis with Polyangiitis Using Methotrexate: Two Case Reports.
TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.
[A case of Churg-Strauss syndrome in which MPO-ANCA (antibodies to myeloperoxidase) appeared to reflect the disease activity]
[ANCA-associated forms of vasculitis]
[Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects]
[Are antineutrophil cytoplasmic antibodies pathogenic?]
[Classification of systemic vasculatides]
[Microscopic polyangiitis]
[New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis]
[The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
Granulomatous Disease, Chronic
A novel post-translational incorporation of tyrosine into multiple proteins in activated human neutrophils. Correlation with phagocytosis and activation of the NADPH oxidase-mediated respiratory burst.
Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and myeloperoxidase-deficient human neutrophils.
Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.
Chemotactic factors trigger their own oxidative inactivation by human neutrophils.
Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD.
Comparison of myeloperoxidase activity in leukocytes from normal subjects and patients with chronic granulomatous disease.
Complete Myeloperoxidase Deficiency: Beware the "False-Positive" Dihydrorhodamine Oxidation.
Confocal Raman microspectroscopy of the activation of single neutrophilic granulocytes.
Cytochemical determination of granulocyte elastase and chymotrypsin in human myeloid cells and its application in acquired deficiency states and diagnosis of myeloid leukemia.
Defective polymorphonuclear leukocyte metabolism and function in canine cyclic neutropenia.
Disorders of neutrophil function: an overview.
Effects of storage and radiation on human neutrophil function in vitro.
Enhanced killing of penicillin-treated gram-positive cocci by human granulocytes: role of bacterial autolysins, catalase, and granulocyte oxidative pathways.
Fungal infections in primary immunodeficiencies.
Further evaluation of luminol-enhanced luminescence in the diagnosis of disorders of leukocyte oxidative metabolism: role of myeloperoxidase.
Genetic disorders of leukocyte function: what they tell us about normal antimicrobial mechanisms of human phagocytic cells.
Genetic immunodeficiencies: cutaneous manifestations and recent progress.
Hydroxyl radical generation by polymorphonuclear leukocytes measured by electron spin resonance spectroscopy.
In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.
Incorporation of glucosamine by activated human neutrophils. A myeloperoxidase-mediated process.
Increased phagocytic activity of polymorphonuclear leukocytes of chronic granulomatous disease as determined with flow cytometric assay.
Influences of chloride and hypochlorite on neutrophil extracellular trap formation.
Invasive fungal infections in congenital immunodeficiencies.
Iodination by human polymorphonuclear leukocytes: a re-evaluation.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes.
Myeloperoxidase-dependent fluorescein chlorination by stimulated neutrophils.
N-acetylcysteine enhances receptor-mediated phagocytosis by human neutrophils.
NADPH oxidase deficiency in X-linked chronic granulomatous disease.
Neutrophil dysfunction and increased susceptibility to infection.
Neutrophil function studies in clinical medicine.
Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae.
Oxidative inactivation of myeloperoxidase released from human neutrophils.
Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways.
Phagocyte defects.
Role of myeloperoxidase and bacterial metabolism in chemiluminescence of granulocytes from patients with chronic granulomatous disease.
Stimulation of the bactericidal activity of polymorphonuclear leukocytes by manganese.
The effect of oxidants on neutrophil-mediated degradation of glomerular basement membrane collagen.
The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
Graves Disease
A Long-term Follow-up of Serum Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Patients with Graves Disease Treated with Propylthiouracil.
A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil.
Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA.
Propylthiouracil-Induced Vasculitis With Alveolar Hemorrhage Confirmed by Clinical, Laboratory, Computed Tomography, and Bronchoscopy Findings: A Case Report and Literature Review.
Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil.
The onset of Graves' disease during the clinical course of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis.
Hearing Loss
AP-VAS 2012 case report: a case of myeloperoxidase antineutrophil cytoplasmic antibody-positive microscopic polyangiitis with rapidly progressive glomerulonephritis and hearing loss.
Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
[A case of microscopic polyangitis accompanied by hearing loss as the initial sign of the disease]
Hearing Loss, Conductive
Is there a relationship between myeloperoxidase activity and conductive hearing loss in chronic otitis media complicated by cholesteatoma?
Hearing Loss, Sensorineural
A patient with myeloperoxidase antineutrophil cytoplasmic antibody-positive polyangiitis who developed sensorineural hearing loss and scleritis.
Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis.
Heart Diseases
Immunomagnetic separation of human myeloperoxidase using an antibody-mimicking peptide identified by phage display.
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.
Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
Heart Failure
Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure.
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.
Evaluation of serum myeloperoxidase concentration in dogs with heart failure due to chronic mitral valvular insufficiency.
Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure.